What benzodiazepines (BZDs) are available in India for various indications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benzodiazepines Available in India

In India, several benzodiazepines are available for clinical use including diazepam, lorazepam, clonazepam, alprazolam, midazolam, and temazepam, which are prescribed for various indications including anxiety disorders, insomnia, seizures, alcohol withdrawal, and acute agitation.

Commonly Available Benzodiazepines in India

Short to Intermediate-Acting Benzodiazepines

  • Alprazolam: Available in tablet form (0.25mg, 0.5mg, 1mg)
  • Lorazepam: Available in tablet and injectable forms (1mg, 2mg)
  • Midazolam: Available primarily in injectable form for procedural sedation and status epilepticus

Intermediate-Acting Benzodiazepines

  • Temazepam: Available in capsule form (7.5mg, 15mg, 22.5mg, 30mg) 1
  • Oxazepam: Less commonly available

Long-Acting Benzodiazepines

  • Diazepam: Available in tablet, injectable, and rectal forms (2mg, 5mg, 10mg)
  • Clonazepam: Available in tablet form (0.5mg, 1mg, 2mg) 2
  • Chlordiazepoxide: Available primarily for alcohol withdrawal syndrome

Clinical Indications and Dosing

Anxiety Disorders

  • Diazepam: 5-10mg PO/IV/IM every 6-8 hours 3
  • Alprazolam: Used for panic disorder and generalized anxiety
  • Clonazepam: Used for panic disorder and social anxiety

Insomnia

  • Temazepam: 15-30mg at bedtime (7.5mg in elderly or debilitated patients) 3
  • Diazepam: Can be used for intermittent dosing

Seizure Management

  • Lorazepam: 1mg IV/SC (up to 2mg maximum) for acute seizures 3
  • Diazepam: For rectal administration when IV access not available 3
  • Clonazepam: For maintenance therapy in certain seizure disorders

Alcohol Withdrawal Syndrome

  • Chlordiazepoxide: 25-100mg PO every 4-6 hours 3
  • Diazepam: 5-10mg PO/IV/IM every 6-8 hours 3
  • Lorazepam: 1-4mg PO/IV/IM every 4-8 hours (preferred in patients with liver failure) 3

Acute Agitation/Delirium

  • Lorazepam: 0.25-0.5mg SC/IV every hour as needed (in combination with antipsychotics for delirious patients with severe agitation) 3
  • Midazolam: 2.5mg SC/IV every hour as needed (up to 5mg maximum) 3

Important Considerations

Safety Concerns

  • Benzodiazepines can cause respiratory depression, especially when combined with other CNS depressants
  • Risk of falls is increased, particularly in elderly patients 3, 4
  • Paradoxical reactions (increased agitation, anxiety) can occur 3
  • Cognitive impairment and delirium risk, especially in older adults 4

Dependence and Withdrawal

  • Physical dependence can develop even with short-term use
  • Gradual tapering (approximately 25% every 1-2 weeks) is recommended when discontinuing 4
  • Withdrawal symptoms may include rebound insomnia, anxiety, irritability, tremors, and sweating 4

Special Populations

  • Elderly: Use lower doses (typically half the adult dose) 3, 4
  • Liver Disease: Prefer lorazepam over diazepam or chlordiazepoxide 3
  • Respiratory Conditions: Use with caution in patients with COPD or sleep apnea 3

Prescribing Pitfalls to Avoid

  • Avoid long-term prescribing when possible (ideally limit to 2-4 weeks) 5
  • Avoid concurrent use with opioids due to risk of fatal overdose 4
  • Avoid abrupt discontinuation after prolonged use
  • Benzodiazepines should not be first-line treatment for chronic insomnia or anxiety disorders where other evidence-based treatments exist 6

For patients requiring long-term anxiety management, consider non-benzodiazepine alternatives such as SSRIs, SNRIs, or buspirone, which do not carry the same risks of dependence and tolerance 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tapering and Management of Benzodiazepines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.